… Association and the American Academy of Neurology to establish the Cure One, Cure Many Award: A research award … decline in cognitive function and is the second most common cause of neurodegenerative dementia, after … to better diagnosis, improved treatments and effective prevention strategies that may benefit millions of people …

… yesterday that their drug candidate Northera, designed to treat orthostatic hypotension in Parkinson’s and other … Those living with the condition — a sudden drop in blood pressure when standing up, which can cause dizziness, falls … concerns about the drug (a highly unusual move) and the company lost a third of its market value in the wake of that …

… ago, we thought Parkinson's had no genetic connection. Today scientists have a growing list of genetic variants and … we do it? Research volunteers give DNA samples; scientists compare and contrast the DNA of people with Parkinson's and … disease . "Genetic research is a bit like a treasure hunt, where each clue unlocks the next," says Dr. Fiske. "These …

… Today, STAT covered the launch of Fox Insight and the … between The Michael J. Fox Foundation and genetics testing company 23andMe to advance the study of Parkinson's … below. Michael J. Fox Foundation partners with 23andMe for precision medicine project on Parkinson's October 30, 2017 …

… Project Description:              The project is divided into 3 phases. The planning phase will be overseen by … phase will involve a team of analysts from the contributing research studies implementing the analytic plan developed in … study might be designed and implemented. Relevance to Diagnosis/Treatment of Parkinson’s Disease:                 …

… By Caroline Gallay One of Houston's major medical claims to fame is that it's home to the … involved in the early development of PPMI. "We have 10,000 visits here per year, so we were in a good position to be … What is a biomarker, exactly? "A biomarker is a clinical test that allows people to track their progression of the …